Loading…

Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells

Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells...

Full description

Saved in:
Bibliographic Details
Published in:ENDOCRINE JOURNAL 1999, Vol.46(6), pp.779-785
Main Authors: TSUMORI, MICHIHIRO, MURAKAMI, YOSHIO, KOSHIMURA, KUNIO, KATO, YUZURU
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613
cites
container_end_page 785
container_issue 6
container_start_page 779
container_title ENDOCRINE JOURNAL
container_volume 46
creator TSUMORI, MICHIHIRO
MURAKAMI, YOSHIO
KOSHIMURA, KUNIO
KATO, YUZURU
description Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells. Inhibiting NOS with NG-nitro-L-arginine or trapping NO with oxyhemoglobin enhanced both the basal and TRH-stimulated rat GH release. Sodium nitroprusside did not further decrease either the basal or the TRH-stimulated GH secretion, suggesting that endogenous NO exerted the maximal inhibitory effect. Inhibition of de novo synthesis of THB increased GH secretion. A cyclic guanosine-monophosphate (cGMP) antagonist did not increase the basal GH secretion but enhanced TRH-induced GH release. These findings suggest that endogenous NO plays an inhibitory role on basal GH release and TRH-stimulated hormone release from GH3 cells in an autocrine or paracrine fashion, at least partly, through a cGMP-dependent pathway. It is also suggested that endogenous THB plays a role in NO production and subsequent inhibition of hormone secretion in GH3 cells.
doi_str_mv 10.1507/endocrj.46.779
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1507_endocrj_46_779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10724353</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613</originalsourceid><addsrcrecordid>eNpNkM1u3CAUhVHUKpmk3XZZ8QKegvkzy2qaeCIlzaLtGmEGjxl5wAWsNts8eZg6ibq5d8E5H_ccAD5htMYMiS_W74KJhzXlayHkGVhhQpuKMoregRWSuKkayeQFuEzpgBAhjJJzcIGRqClhZAWergtgb32YE_zucnQGPvx1Owtv_eA6lxNsY_iTB7gN8Ri8hT-siTa74GEeYpj3A9w8mrHY2ln7kFyR3AcfpiGkadDZVt_sVI60PsN7awbtXTom6DxstwRu7DimD-B9r8dkP77sK_Dr5vrnZlvdPbS3m693lSlpZEVRx5nlTOIec400QbXWkvDa0o4KgRHjWHIj-h2XojZSsl4zSTpBqZacY3IF1gvXxJBStL2aojvq-KgwUqcy1UuZinJVyiyGz4thmruj3f0nX9orgptFUF6d0WPwY8mvDmGOviRR5jf_h1RYSqkQohzxsphCBV9Gw5q6aSgroHYBHVLWe_v2k47ZmdG-HlYw5HQcX8YJ8qoozcYiI88s8qJJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells</title><source>J-STAGE Free Content</source><creator>TSUMORI, MICHIHIRO ; MURAKAMI, YOSHIO ; KOSHIMURA, KUNIO ; KATO, YUZURU</creator><creatorcontrib>TSUMORI, MICHIHIRO ; MURAKAMI, YOSHIO ; KOSHIMURA, KUNIO ; KATO, YUZURU ; First Division ; Department of Medicine ; Shimane Medical University</creatorcontrib><description>Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells. Inhibiting NOS with NG-nitro-L-arginine or trapping NO with oxyhemoglobin enhanced both the basal and TRH-stimulated rat GH release. Sodium nitroprusside did not further decrease either the basal or the TRH-stimulated GH secretion, suggesting that endogenous NO exerted the maximal inhibitory effect. Inhibition of de novo synthesis of THB increased GH secretion. A cyclic guanosine-monophosphate (cGMP) antagonist did not increase the basal GH secretion but enhanced TRH-induced GH release. These findings suggest that endogenous NO plays an inhibitory role on basal GH release and TRH-stimulated hormone release from GH3 cells in an autocrine or paracrine fashion, at least partly, through a cGMP-dependent pathway. It is also suggested that endogenous THB plays a role in NO production and subsequent inhibition of hormone secretion in GH3 cells.</description><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.46.779</identifier><identifier>PMID: 10724353</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Animals ; Biopterins - analogs &amp; derivatives ; Biopterins - physiology ; Cell Line ; Cyclic GMP ; Cyclic GMP - analogs &amp; derivatives ; Cyclic GMP - antagonists &amp; inhibitors ; Cyclic GMP - pharmacology ; Cyclic GMP - physiology ; Dose-Response Relationship, Drug ; Drug Synergism ; Enzyme Inhibitors - pharmacology ; GH3 cells ; Growth Hormone - metabolism ; Nitric oxide ; Nitric Oxide - physiology ; Oxyhemoglobins - pharmacology ; Rats ; Tetrahydrobiopterin ; Thionucleotides - pharmacology ; Thyrotropin-Releasing Hormone - pharmacology</subject><ispartof>Endocrine Journal, 1999, Vol.46(6), pp.779-785</ispartof><rights>The Japan Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1882,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10724353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TSUMORI, MICHIHIRO</creatorcontrib><creatorcontrib>MURAKAMI, YOSHIO</creatorcontrib><creatorcontrib>KOSHIMURA, KUNIO</creatorcontrib><creatorcontrib>KATO, YUZURU</creatorcontrib><creatorcontrib>First Division</creatorcontrib><creatorcontrib>Department of Medicine</creatorcontrib><creatorcontrib>Shimane Medical University</creatorcontrib><title>Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells</title><title>ENDOCRINE JOURNAL</title><addtitle>Endocr J</addtitle><description>Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells. Inhibiting NOS with NG-nitro-L-arginine or trapping NO with oxyhemoglobin enhanced both the basal and TRH-stimulated rat GH release. Sodium nitroprusside did not further decrease either the basal or the TRH-stimulated GH secretion, suggesting that endogenous NO exerted the maximal inhibitory effect. Inhibition of de novo synthesis of THB increased GH secretion. A cyclic guanosine-monophosphate (cGMP) antagonist did not increase the basal GH secretion but enhanced TRH-induced GH release. These findings suggest that endogenous NO plays an inhibitory role on basal GH release and TRH-stimulated hormone release from GH3 cells in an autocrine or paracrine fashion, at least partly, through a cGMP-dependent pathway. It is also suggested that endogenous THB plays a role in NO production and subsequent inhibition of hormone secretion in GH3 cells.</description><subject>Animals</subject><subject>Biopterins - analogs &amp; derivatives</subject><subject>Biopterins - physiology</subject><subject>Cell Line</subject><subject>Cyclic GMP</subject><subject>Cyclic GMP - analogs &amp; derivatives</subject><subject>Cyclic GMP - antagonists &amp; inhibitors</subject><subject>Cyclic GMP - pharmacology</subject><subject>Cyclic GMP - physiology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Synergism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>GH3 cells</subject><subject>Growth Hormone - metabolism</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - physiology</subject><subject>Oxyhemoglobins - pharmacology</subject><subject>Rats</subject><subject>Tetrahydrobiopterin</subject><subject>Thionucleotides - pharmacology</subject><subject>Thyrotropin-Releasing Hormone - pharmacology</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpNkM1u3CAUhVHUKpmk3XZZ8QKegvkzy2qaeCIlzaLtGmEGjxl5wAWsNts8eZg6ibq5d8E5H_ccAD5htMYMiS_W74KJhzXlayHkGVhhQpuKMoregRWSuKkayeQFuEzpgBAhjJJzcIGRqClhZAWergtgb32YE_zucnQGPvx1Owtv_eA6lxNsY_iTB7gN8Ri8hT-siTa74GEeYpj3A9w8mrHY2ln7kFyR3AcfpiGkadDZVt_sVI60PsN7awbtXTom6DxstwRu7DimD-B9r8dkP77sK_Dr5vrnZlvdPbS3m693lSlpZEVRx5nlTOIec400QbXWkvDa0o4KgRHjWHIj-h2XojZSsl4zSTpBqZacY3IF1gvXxJBStL2aojvq-KgwUqcy1UuZinJVyiyGz4thmruj3f0nX9orgptFUF6d0WPwY8mvDmGOviRR5jf_h1RYSqkQohzxsphCBV9Gw5q6aSgroHYBHVLWe_v2k47ZmdG-HlYw5HQcX8YJ8qoozcYiI88s8qJJ</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>TSUMORI, MICHIHIRO</creator><creator>MURAKAMI, YOSHIO</creator><creator>KOSHIMURA, KUNIO</creator><creator>KATO, YUZURU</creator><general>The Japan Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1999</creationdate><title>Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells</title><author>TSUMORI, MICHIHIRO ; MURAKAMI, YOSHIO ; KOSHIMURA, KUNIO ; KATO, YUZURU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Biopterins - analogs &amp; derivatives</topic><topic>Biopterins - physiology</topic><topic>Cell Line</topic><topic>Cyclic GMP</topic><topic>Cyclic GMP - analogs &amp; derivatives</topic><topic>Cyclic GMP - antagonists &amp; inhibitors</topic><topic>Cyclic GMP - pharmacology</topic><topic>Cyclic GMP - physiology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Synergism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>GH3 cells</topic><topic>Growth Hormone - metabolism</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - physiology</topic><topic>Oxyhemoglobins - pharmacology</topic><topic>Rats</topic><topic>Tetrahydrobiopterin</topic><topic>Thionucleotides - pharmacology</topic><topic>Thyrotropin-Releasing Hormone - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TSUMORI, MICHIHIRO</creatorcontrib><creatorcontrib>MURAKAMI, YOSHIO</creatorcontrib><creatorcontrib>KOSHIMURA, KUNIO</creatorcontrib><creatorcontrib>KATO, YUZURU</creatorcontrib><creatorcontrib>First Division</creatorcontrib><creatorcontrib>Department of Medicine</creatorcontrib><creatorcontrib>Shimane Medical University</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>ENDOCRINE JOURNAL</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TSUMORI, MICHIHIRO</au><au>MURAKAMI, YOSHIO</au><au>KOSHIMURA, KUNIO</au><au>KATO, YUZURU</au><aucorp>First Division</aucorp><aucorp>Department of Medicine</aucorp><aucorp>Shimane Medical University</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells</atitle><jtitle>ENDOCRINE JOURNAL</jtitle><addtitle>Endocr J</addtitle><date>1999</date><risdate>1999</risdate><volume>46</volume><issue>6</issue><spage>779</spage><epage>785</epage><pages>779-785</pages><issn>0918-8959</issn><eissn>1348-4540</eissn><abstract>Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells. Inhibiting NOS with NG-nitro-L-arginine or trapping NO with oxyhemoglobin enhanced both the basal and TRH-stimulated rat GH release. Sodium nitroprusside did not further decrease either the basal or the TRH-stimulated GH secretion, suggesting that endogenous NO exerted the maximal inhibitory effect. Inhibition of de novo synthesis of THB increased GH secretion. A cyclic guanosine-monophosphate (cGMP) antagonist did not increase the basal GH secretion but enhanced TRH-induced GH release. These findings suggest that endogenous NO plays an inhibitory role on basal GH release and TRH-stimulated hormone release from GH3 cells in an autocrine or paracrine fashion, at least partly, through a cGMP-dependent pathway. It is also suggested that endogenous THB plays a role in NO production and subsequent inhibition of hormone secretion in GH3 cells.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>10724353</pmid><doi>10.1507/endocrj.46.779</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-8959
ispartof Endocrine Journal, 1999, Vol.46(6), pp.779-785
issn 0918-8959
1348-4540
language eng
recordid cdi_crossref_primary_10_1507_endocrj_46_779
source J-STAGE Free Content
subjects Animals
Biopterins - analogs & derivatives
Biopterins - physiology
Cell Line
Cyclic GMP
Cyclic GMP - analogs & derivatives
Cyclic GMP - antagonists & inhibitors
Cyclic GMP - pharmacology
Cyclic GMP - physiology
Dose-Response Relationship, Drug
Drug Synergism
Enzyme Inhibitors - pharmacology
GH3 cells
Growth Hormone - metabolism
Nitric oxide
Nitric Oxide - physiology
Oxyhemoglobins - pharmacology
Rats
Tetrahydrobiopterin
Thionucleotides - pharmacology
Thyrotropin-Releasing Hormone - pharmacology
title Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A22%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endogenous%20Nitric%20Oxide%20Inhibits%20Growth%20Hormone%20Secretion%20through%20Cyclic%20Guanosine%20Monophosphate-Dependent%20Mechanisms%20in%20GH3%20Cells&rft.jtitle=ENDOCRINE%20JOURNAL&rft.au=TSUMORI,%20MICHIHIRO&rft.aucorp=First%20Division&rft.date=1999&rft.volume=46&rft.issue=6&rft.spage=779&rft.epage=785&rft.pages=779-785&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.46.779&rft_dat=%3Cpubmed_cross%3E10724353%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/10724353&rfr_iscdi=true